PubMed HealthSearch

PubMed · 7288651

[Increase in binding affinity of the 5-HT receptor and decrease in 5-HT sensitive adenylate cyclase activity following prolonged exposure to 5-HT (author's transl)].

Abstract

Previously, a 5-hydroxytryptamine receptor has been described in neuronal membrane preparations. This receptor corresponds to a recognition site for 5-HT, and is seemingly related to an effector which consists of an adenylate cyclase activated by 5-HT and having a high apparent affinity constant (KD close to 1 nM). Moreover, this neuronal receptor is distinct of the glial serotoninergic receptor (Fillion et al., 1980). The method used to measure the binding of 3H-5-HT has been previously reported (FILLION et al., 1978). Adenylate cyclase activity was determined by measurement of cAMP using a radioimmunoassay (FILLION et al., 1979 a, b). Membranes were pretreated as follows: (1) membranes were preexposed to 5-HT (i.e.: incubated in the presence of 5-HT, generally 10 nM) at 37 degrees C, washed by centrifugation and resuspended in a medium free of 5-HT (or diluted in the same medium) or (2) membranes were incubated with a single concentration of 5-HT for a prolonged duration. Results were as follows: 1. The binding of 3H-5-HT, incubated for 10 min at 37 degrees C, corresponds to a KD close to 20 nM whereas a prolongation of the incubation duration to 15-25 induces the binding of 5-HT with a KD close to 2 nM. 2. Preexposure of the membranes to 5-HT leads to the same increase in affinity with, apparently, a reduced number of sites. 3. N-ethylmaleimide pretreatment of the membranes prior to their preexposure to 5-HT inhibits the change in affinity. 4. GTP, but not GDP, reverses the affinity change. 5. The adenylate cyclase activated by 5-HT is desensitized by preexposure of the membranes to 5-HT. 6. GTP reverses the process of desensitization. These results support the hypothesis of the existence of a regulatory mechanism for the 5-HT neuronal receptor. The regulatory mechanism would involve structural conformation changes of the recognition site corresponding to different affinities of the adenylate cyclase. A nucleotide binding protein is presumably involved in the coupling of these two subunits of the receptor.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Fillion, M P Fillion, J C Rousselle. 1981. [Increase in binding affinity of the 5-HT receptor and decrease in 5-HT sensitive adenylate cyclase activity following prolonged exposure to 5-HT (author's transl)].. https://pubmed.ncbi.nlm.nih.gov/7288651/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse.

Rapid expansion of available data, both phenotypic and genotypic, for multiple strains of mice has enabled the development of new methods to interrogate the mouse genome for functional genetic perturbations. In silico mapping provides an expedient way to associate the natural diversity of phenotypic traits with ancestrally inherited polymorphisms for the purpose of dissecting genetic traits. In mouse, the current single nucleotide polymorphism (SNP) data have lacked the density across the genome and coverage of enough strains to properly achieve this goal. To remedy this, 470,407 allele calls were produced for 10,990 evenly spaced SNP loci across 48 inbred mouse strains. Use of the SNP set with statistical models that considered unique patterns within blocks of three SNPs as an inferred haplotype could successfully map known single gene traits and a cloned quantitative trait gene. Application of this method to high-density lipoprotein and gallstone phenotypes reproduced previously characterized quantitative trait loci (QTL). The inferred haplotype data also facilitates the refinement of QTL regions such that candidate genes can be more easily identified and characterized as shown for adenylate cyclase 7.

Adenylyl Cyclases

In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor.

We examined the signaling function of the IGF-II/mannose 6-phosphate receptor (IGF-IIR) by transfecting IGF-IIR cDNAs into COS cells, where adenylyl cyclase (AC) was inhibited by transfection of constitutively activated G alpha i cDNA (G alpha i2Q205L). In cells transfected with IGF-IIR cDNA, IGF-II decreased cAMP accumulation promoted by cholera toxin or forskolin. This effect of IGF-II was not observed in untransfected cells or in cells transfected with IGF-IIRs lacking Arg2410-Lys2423. Thus, IGF-IIR, through its cytoplasmic domain, mediates the Gi-linked action of IGF-II in living cells. We also found that IGF-IIR truncated with C-terminal 28 residues after Ser2424 caused G beta gamma-dominant response of AC in response to IGF-II by activating Gi. Comparison with the G alpha i-dominant response of AC by intact IGF-IIR suggests that the C-terminal 28-residue region inactivates G beta gamma. This study not only provides further evidence that IGF-IIR has IGF-II-dependent signaling function to interact with heteromeric G proteins with distinct roles by different cytoplasmic domains, it also suggests that IGF-IIR can separate and sequestrate the G alpha and G beta gamma signals following Gi activation.

Adenylyl Cyclases

Targeted disruption of the beta 3-adrenergic receptor gene.

beta 3-Adrenergic receptors (beta 3-ARs) are expressed predominantly in white and brown adipose tissue, and beta 3-selective agonists are potential anti-obesity drugs. However, the role of beta 3-ARs in normal physiology is unknown. To address this issue, homologous recombination was used to generate mice that lack beta 3-ARs. This was accomplished by direct injection of a DNA-targeting construct into mouse zygotes. Twenty-three transgenic mice were generated, of which two had targeted disruption of the beta 3-AR gene. Mice that were homozygous for the disrupted allele had undetectable levels of intact beta 3-AR mRNA, as assessed by RNase protection assay and Northern blotting, and lacked functional beta 3-ARs, as demonstrated by complete loss of beta 3-agonist (CL 316,243)-induced stimulation of adenylate cyclase activity and lipolysis. beta 3-AR-deficient mice had modestly increased fat stores (females more than males), indicating that beta 3-ARs play a role in regulating energy balance. Importantly, beta 1 but not beta 2-AR mRNA levels up-regulated in white and brown adipose tissue of beta 3-AR-deficient mice (brown more than white), strongly implying that beta 3-ARs mediate physiologically relevant signaling under normal conditions and that "cross-talk" exists between beta 3-ARs and beta 1-AR gene expression. Finally, acute treatment of normal mice with CL 316,243 increased serum levels of free fatty acids (FFAs) (3.2-fold) and insulin (140-fold), increased energy expenditure (2-fold), and reduced food intake (by 45%). These effects were completely absent in beta 3-AR-deficient mice, proving that the actions of CL are mediated exclusively by beta 3-ARs. beta 3-AR-deficient mice should be useful as a means to a better understanding of the physiology and pharmacology of beta 3-ARs.

Adenylyl Cyclases